Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 12:57PM ET
32.30
Dollar change
+0.58
Percentage change
1.82
%
IndexRUT P/E- EPS (ttm)-3.77 Insider Own17.17% Shs Outstand164.67M Perf Week-0.41%
Market Cap5.32B Forward P/E- EPS next Y-3.41 Insider Trans-0.56% Shs Float136.41M Perf Month7.80%
Income-436.37M PEG- EPS next Q-0.75 Inst Own78.97% Short Float12.03% Perf Quarter10.19%
Sales11.58M P/S459.32 EPS this Y17.78% Inst Trans8.24% Short Ratio11.92 Perf Half Y11.75%
Book/sh11.09 P/B2.91 EPS next Y-7.49% ROA-29.82% Short Interest16.40M Perf Year55.50%
Cash/sh11.25 P/C2.87 EPS next 5Y- ROE-34.75% 52W Range15.44 - 35.60 Perf YTD12.61%
Dividend Est.- P/FCF- EPS past 5Y-36.05% ROI-22.89% 52W High-9.28% Beta1.54
Dividend TTM- Quick Ratio13.06 Sales past 5Y11.11% Gross Margin19.61% 52W Low109.17% ATR (14)1.34
Dividend Ex-Date- Current Ratio13.06 EPS Y/Y TTM-21.72% Oper. Margin-4207.12% RSI (14)57.73 Volatility4.49% 4.56%
Employees378 Debt/Eq0.05 Sales Y/Y TTM-67.27% Profit Margin-3768.28% Recom1.08 Target Price38.83
Option/ShortYes / Yes LT Debt/Eq0.04 EPS Q/Q-80.53% Payout- Rel Volume0.28 Prev Close31.72
Sales Surprise11.29% EPS Surprise-33.66% Sales Q/Q-95.16% EarningsFeb 26 AMC Avg Volume1.38M Price32.30
SMA203.32% SMA508.20% SMA20017.10% Trades Volume211,662 Change1.82%
Date Action Analyst Rating Change Price Target Change
Mar-11-24Initiated Piper Sandler Overweight $43
Jan-05-24Upgrade BofA Securities Neutral → Buy $31 → $34
Jan-04-24Initiated Wedbush Outperform $41
Nov-16-23Initiated Raymond James Outperform $30
Feb-28-23Upgrade JP Morgan Neutral → Overweight $32 → $38
Dec-14-22Initiated Needham Buy $31
Oct-21-22Initiated Oppenheimer Outperform $30
May-20-22Initiated BofA Securities Neutral $24
Mar-01-22Upgrade Stifel Hold → Buy $36 → $26
Sep-23-21Initiated Stifel Hold $34
Feb-26-24 05:20PM
04:05PM
Feb-20-24 04:05PM
Feb-01-24 04:05PM
Jan-17-24 09:55AM
07:00AM Loading…
Jan-04-24 07:00AM
Nov-09-23 09:10AM
Nov-08-23 11:30AM
Nov-07-23 10:14AM
Nov-06-23 05:50PM
04:55PM
04:05PM
Nov-01-23 07:00AM
Oct-31-23 04:15PM
Oct-23-23 04:06PM
01:48PM Loading…
01:48PM
12:04PM
10:07AM
Oct-22-23 02:30AM
Oct-19-23 07:02AM
Oct-16-23 03:19PM
09:45AM
Oct-13-23 02:54PM
11:50AM
Oct-04-23 04:05PM
Sep-20-23 07:01AM
Sep-19-23 07:00AM
Aug-17-23 04:05PM
Aug-09-23 02:13PM
Aug-08-23 05:50PM
04:05PM Loading…
04:05PM
Aug-03-23 04:05PM
Aug-01-23 02:34PM
07:00AM
Jul-06-23 09:59AM
Jun-09-23 08:29AM
Jun-08-23 04:05PM
May-24-23 04:05PM
May-13-23 08:19AM
May-10-23 06:10AM
May-09-23 09:40AM
May-08-23 05:25PM
04:02PM
May-03-23 10:00AM
09:55AM
May-01-23 04:05PM
10:01AM
Apr-19-23 07:15AM
Apr-13-23 04:05PM
Apr-06-23 07:00AM
Mar-22-23 11:29AM
Mar-11-23 03:27AM
Mar-07-23 04:02PM
Mar-02-23 09:15PM
Mar-01-23 04:17PM
Feb-27-23 06:25PM
04:05PM
Feb-21-23 04:05PM
Feb-02-23 12:00PM
07:00AM
Jan-23-23 05:31AM
Jan-12-23 03:25AM
Jan-03-23 07:00AM
Dec-31-22 06:15AM
Dec-26-22 08:14AM
Dec-19-22 07:00AM
Dec-08-22 06:19AM
Dec-07-22 04:05PM
Nov-10-22 05:48AM
Nov-09-22 04:05PM
Nov-07-22 05:55PM
04:05PM
Nov-02-22 10:01AM
09:54AM
Nov-01-22 04:05PM
Oct-24-22 11:07AM
Oct-13-22 11:05AM
Sep-22-22 07:00AM
Sep-01-22 04:05PM
Aug-31-22 04:05PM
Aug-30-22 09:55AM
Aug-12-22 09:55AM
Aug-10-22 08:35AM
Aug-09-22 06:15PM
04:02PM
Jul-28-22 04:02PM
Jul-22-22 04:02PM
Jul-19-22 10:41PM
04:01PM
07:16AM
Jul-13-22 07:00AM
Jun-28-22 07:00AM
Jun-24-22 09:42AM
Jun-09-22 04:02PM
May-11-22 06:22AM
May-09-22 05:35PM
04:02PM
May-06-22 09:50AM
May-05-22 08:05PM
Apr-21-22 04:05PM
Revolution Medicines, Inc. is a clinical-stage precision oncology company, which engages in developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GOLDSMITH MARK ASee RemarksMar 18 '24Sale31.585,788182,804460,379Mar 20 04:44 PM
Horn Margaret AChief Operating OfficerMar 18 '24Sale31.582,91492,033139,553Mar 20 04:44 PM
Kelsey Stephen MichaelSee RemarksMar 18 '24Sale31.582,12367,051270,909Mar 20 04:45 PM
Anders JackChief Financial OfficerMar 18 '24Sale31.581,26139,826101,959Mar 20 04:43 PM
Cislini JeffGeneral CounselMar 18 '24Sale31.581,25239,54255,874Mar 20 04:45 PM
Horn Margaret AChief Operating OfficerMar 12 '24Option Exercise4.097,93632,458150,403Mar 13 04:32 PM
Horn Margaret AChief Operating OfficerMar 12 '24Sale34.077,936270,345142,467Mar 13 04:32 PM
Horn Margaret AChief Operating OfficerMar 11 '24Option Exercise4.0915,73564,356158,202Mar 13 04:32 PM
Horn Margaret AChief Operating OfficerMar 11 '24Sale34.0215,735535,306142,467Mar 13 04:32 PM
Cislini JeffGeneral CounselJan 22 '24Sale27.001,50040,50036,126Jan 24 04:12 PM
Kelsey Stephen MichaelSee RemarksJan 08 '24Sale29.013,33796,809221,632Jan 10 04:26 PM
Kelsey Stephen MichaelSee RemarksJan 02 '24Sale29.1013,330387,884224,969Jan 04 04:06 PM
Kelsey Stephen MichaelSee RemarksDec 27 '23Sale29.0133,334966,996238,299Dec 29 04:14 PM
GOLDSMITH MARK ASee RemarksDec 18 '23Sale25.908,165211,488376,167Dec 20 05:08 PM
Horn Margaret AChief Operating OfficerDec 18 '23Sale25.902,99377,524101,467Dec 19 07:30 PM
Kelsey Stephen MichaelSee RemarksDec 18 '23Sale25.902,08854,083271,633Dec 20 05:07 PM
Anders JackChief Financial OfficerDec 18 '23Sale25.901,77545,97676,416Dec 20 05:10 PM
Cislini JeffGeneral CounselDec 18 '23Sale25.901,22931,83337,284Dec 20 05:08 PM
Horn Margaret AChief Operating OfficerDec 15 '23Option Exercise4.095,00020,450109,460Dec 19 07:30 PM
Horn Margaret AChief Operating OfficerDec 15 '23Sale26.645,000133,183104,460Dec 19 07:30 PM
Horn Margaret AChief Operating OfficerDec 06 '23Option Exercise4.095,00020,450109,460Dec 08 04:08 PM
Horn Margaret AChief Operating OfficerDec 06 '23Sale25.005,000125,000104,460Dec 08 04:08 PM
Cislini JeffGeneral CounselNov 20 '23Sale21.701,50032,54538,513Nov 20 06:24 PM
Horn Margaret AChief Operating OfficerOct 25 '23Option Exercise0.547,5004,050104,460Oct 25 06:20 PM
GOLDSMITH MARK ASee RemarksOct 24 '23Option Exercise0.4935,00017,150384,332Oct 24 07:21 PM
Anders JackChief Financial OfficerOct 23 '23Option Exercise2.9824,52472,96778,191Oct 23 06:01 PM
Horn Margaret AChief Operating OfficerOct 16 '23Option Exercise4.0925,000102,250121,960Oct 18 04:23 PM
Horn Margaret AChief Operating OfficerOct 16 '23Sale33.9525,000848,80696,960Oct 18 04:23 PM
Kelsey Stephen MichaelSee RemarksOct 11 '23Sale29.0516,667484,130273,721Oct 13 04:20 PM
Cislini JeffGeneral CounselSep 28 '23Sale28.202,00056,39440,013Oct 02 04:12 PM
GOLDSMITH MARK ASee RemarksSep 18 '23Sale31.318,054252,175349,332Sep 20 04:12 PM
Horn Margaret AChief Operating OfficerSep 18 '23Sale31.312,51478,71596,960Sep 19 04:17 PM
Kelsey Stephen MichaelSee RemarksSep 18 '23Sale31.312,06064,500290,388Sep 20 04:13 PM
Anders JackChief Financial OfficerSep 18 '23Sale31.311,42744,68053,667Sep 20 04:11 PM
Cislini JeffGeneral CounselSep 18 '23Sale31.311,21438,01142,013Sep 20 04:11 PM
Horn Margaret AChief Operating OfficerSep 15 '23Option Exercise4.095,00020,450104,474Sep 19 04:17 PM
Horn Margaret AChief Operating OfficerSep 15 '23Sale32.085,000160,40899,474Sep 19 04:17 PM
Weber BarbaraDirectorSep 01 '23Option Exercise3.8015,00057,03730,825Sep 06 08:03 PM
Anders JackChief Financial OfficerSep 01 '23Option Exercise2.6820,00053,60075,094Sep 06 08:02 PM
GOLDSMITH MARK ASee RemarksSep 01 '23Option Exercise0.7730,00023,164387,386Sep 06 08:05 PM
GOLDSMITH MARK ASee RemarksSep 01 '23Sale35.0530,0001,051,563357,386Sep 06 08:05 PM
Anders JackChief Financial OfficerSep 01 '23Sale35.0520,000701,09255,094Sep 06 08:02 PM
Weber BarbaraDirectorSep 01 '23Sale35.0715,000526,00015,825Sep 06 08:03 PM
GOLDSMITH MARK ASee RemarksSep 01 '23Sale35.0410,000350,41035,424Sep 06 08:05 PM
Horn Margaret AChief Operating OfficerAug 31 '23Option Exercise4.0910,00040,900109,474Sep 01 04:16 PM
Horn Margaret AChief Operating OfficerAug 31 '23Sale34.0510,000340,45899,474Sep 01 04:16 PM
Horn Margaret AChief Operating OfficerAug 15 '23Option Exercise4.095,00020,450104,474Aug 17 04:17 PM
Horn Margaret AChief Operating OfficerAug 15 '23Sale30.535,000152,63299,474Aug 17 04:17 PM
Kelsey Stephen MichaelSee RemarksAug 02 '23Sale32.4016,666539,978292,448Aug 03 04:17 PM
Kelsey Stephen MichaelSee RemarksAug 01 '23Sale29.1916,666486,502309,114Aug 03 04:17 PM
Cislini JeffGeneral CounselJul 31 '23Sale26.021,50039,03043,227Aug 01 06:23 PM
Kelsey Stephen MichaelSee RemarksJun 20 '23Sale24.892,10252,321325,780Jun 22 04:26 PM
Horn Margaret AChief Operating OfficerJun 20 '23Sale24.892,10252,32199,474Jun 22 04:26 PM
Cislini JeffGeneral CounselJun 20 '23Sale25.141,23931,14844,727Jun 22 04:24 PM
Anders JackChief Financial OfficerJun 20 '23Sale24.891,24931,08955,094Jun 22 04:25 PM